Madrigal Pharmaceuticals, Inc. number of employees

Madrigal Pharmaceuticals, Inc. reported 915 employees at December 31, 2025 in its latest annual report, up 387 (73.3%) on the year before. That compares with 376 at December 31, 2023. Revenue per employee was $1.0m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	915	+387 (73.3%)	$1.0m	10-K, filed February 19, 2026
December 31, 2024	528	+152 (40.4%)	$341,161	10-K, filed February 26, 2025
December 31, 2023	376	—	—	10-K, filed February 28, 2024

What the annual reports say

Human Capital As of December 31, 2025, we had 915 full-time employees, including 258 engaged in research, development and medical affairs, 526 in commercial activities and 131 in general and administrative functions. 2025 annual report
Human Capital As of December 31, 2024, we had 528 full-time employees, including 136 engaged in research, development and medical affairs, 312 in commercial activities and 80 in general and administrative functions. 2024 annual report
Human Capital As of February 22, 2024, we had 376 full-time employees, including 99 engaged in research, development, and regulatory activities, and 277 in executive, commercial, general and administrative functions, and multiple part-time consultants. 2023 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: INSM vs MDGL HALO vs MDGL ALKS vs MDGL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Madrigal Pharmaceuticals, Inc.